Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

γ‐Oryzanol ointment increases sebaceous gland activity and sebum production.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Potassium channel openers like minoxidil boost hair growth.

Oral Minoxidil is a practical alternative to Topical Minoxidil for hair loss, but treatment should be personalized.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

AVT is highly conserved and may have antimicrobial properties.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Onyx® embolization effectively treats facial arteriovenous malformations with minimal complications.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Finasteride reduces opioid use and withdrawal symptoms in animals.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Topical 0.1% tacrolimus improved a rare ear condition in cats.

Lowering the dose of ziprasidone can cause sudden restlessness and urge to move in patients.